Open-Label Dose-Escalation Trial to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of Daily Oral MGCD265 Administered Without Interruption to Subjects With Advanced Malignancies

UCI-13-49
NCT00697632
Cancer - Larynx, Cancer - Lip, Oral Cavity and Pharynx, Cancer - Lung
Sai-Hong Ignatius Ou
Open
Treatment
MGCD265
I
Adult
Local

For information about cancer clinical trials at the UC Irvine Health Chao Family Comprehensive Cancer Center, call toll-free 877-UC-STUDY (877-827-8839) or email ucstudy@uci.edu.